Dr Robert Shaw
MA (Cantab), MSci (Cantab), MBBS (Imp), MRCP (UK), DPhil (Oxon)
Senior Vaccine Clinical Trials Physician
- Principal Investigator | Oxford Vaccine Group
- Co-lead Infection & Immunity Module, Graduate Entry Medicine Course | University of Oxford
- Honorary Consultant Physician | Oxford University Hospitals NHS Foundation Trust
- Infectious Diseases & Medical Microbiology Physician
Recent publications
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.
Journal article
Amini A. et al, (2025), Sci Immunol, 10
ge differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).
Journal article
Belij-Rammerstorfer S. et al, (2025), EBioMedicine, 118
Homologous & heterologous COVID-19 vaccine priming schedules: an analysis of systemic & mucosal immunity
Thesis / Dissertation
Shaw R., (2024)
Nasally delivered SARS-CoV-2 vaccines: future promise and challenges.
Journal article
Shaw RH., (2023), Lancet Respir Med, 11, 1038 - 1039
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Journal article
Shaw RH. et al, (2023), J Infect, 86, 574 - 583